Speaker
Description
Background: Breast cancer is a leading cause of cancer mortality in Georgia (43 deaths per 100 000 in 2020), yet national screening uptake was only 16% in 2023. Our study examines patient-perceived and system barriers to early detection among self- and screen-detected women.
Methods: DEDICA Georgia is a cross-sectional study that enrolled women aged ≥18 years with newly diagnosed breast cancer. Pathway intervals were measured from symptom discovery (self-detected) or screening (screen-detected). Within each group, intervals were compared by patient-reported barriers using Kruskal-Wallis tests with Benjamini-Hochberg (FDR) correction.
Results: Of 201 women, 161 (80.1%) self-detected their cancer; 65% had never received in-person education from a healthcare worker. Self-detected women more often presented at stage III-IV (39.9% vs 11.4%; p=0.001). Their median symptom-to-first-consultation was 52.5 days (IQR 13-138.5), longer among women who waited for symptoms to resolve (133 vs 14 days), reported competing priorities (178 vs 32 days) or health system/access barriers (116.5 vs 32 days; all FDR-adjusted p<0.05). Screen-detected women, mostly entering at specialist level, had a median screening-to-diagnosis of 25 days (IQR 15-42). Diagnosis-to-treatment intervals were similar (25 vs 21 days; p=0.47).
Conclusion: For self-detected women, delay arose mainly before first consultation and was linked to waiting for symptoms to resolve, competing priorities and access barriers, supporting awareness campaigns and primary healthcare-led education. For screen-detected women, the main interval was between screening and diagnosis, supporting better integration of screening with diagnostic services. Moreover, improving early diagnosis in Georgia would be strengthened through tailored navigation according to each detection pathway.
Word count: 250